No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-Hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF

Stem Cells and Development

Volumn 15, Issue 2, 2006, Pages 269-277

  Gazitt, Yair ^a,b   Akay, Cagla ^a   Thomas III, Charles ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTIGEN PRESENTING CELL; APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CRYOPRESERVATION; DENDRITIC CELL; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEM CELL MOBILIZATION; TH1 CELL; TH2 CELL;

ADULT; AGED; ANTIGENS, CD11C; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; BONE MARROW; CYCLOPHOSPHAMIDE; DENDRITIC CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-3; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33646542654     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.269     Document Type: Article

References (30)

1. Kotasek D, KM Shepherd, RE Sage, et al. (1992) Factors affecting blood stem cell collection following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplantation 9:11-17.
2. Haas R, R Mohle, S Fruhauf, et al. (1994). Patient characteristic associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794.
3. Bensinger WI, F Appelbaum, S Rowley, et al. (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2547-2555.
4. Watts MJ, AM Sullivan, E Jamieson, et al. (1997). Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 15:535-546.
5. + progenitor cell collection in patients with hematological malignancies. Am J Hematol 58:255-262.
6. + cell yields. J Hematother 7:241-249.
7. Weaver CH, K Tauer, B Zhen, et al. (1998). Second attempt at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields. J Hematother 7:241-249.
8. Gazitt Y, N Callander, CO Freytes, et al. (2000). Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF in non Hodgkin's lymphoma patients: a randomized prospective study. J Hematother Stem Cell Res 9:737-748.
9. Gazitt Y, CO Freytes, N Callander, et al. (1999). Successful PBSC mobilization with high dose G-CSF for patients failing a first round of mobilization. J Hematother 8:173-183.
10. + cells mobilized with different growth factors. Stem Cells 18:390-398.
11. Gazitt Y. (2001). Recent developments in the regulation of peripheral blood stem cell mobilization. J Hematother Stem Cell Res 10:229-236.
12. Gazitt Y. (2002). Comparison between G-CSF and GM-CSF in the mobilization of peripheral blood stem cells. Curr Opin Hematol 9:190-198.
13. Bernhard H, ML Disis, S Heimfeld, et al. (1995). Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Blood 87:1292-1302.
14. Gazitt Y, P Shaughnessy, and P Devore. (2001). Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors. J Hematother Stem Cell Res 10:177-186.
15. Lanzavecchia A and F Sallusto. (2001). The instuctive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2:725-731.
16. Shortman K and Y-J Liu. (2002). Mouse and human dendritic cell subtypes. Nature Rev Immunol 2:151-161.
17. Takeda K and S Akira. (2004). TLR signaling pathways. Semin Immunol 16:3-9.
18. Avigan D, Z Wu, J Gong, et al. (1999). Selective in vivo mobilization with grunulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation. Clin Cancer Res 5:2735-2741.
19. Arpinati M, CL Green, S Heimfeld, et al. (2000). Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95:2484-2490.
20. Hock BD, LF Haring, AM Ebbett, et al. (2002). Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation. Bone Marrow Transplant 30:733-740.
21. Klangsinsirikul P and NH Russell. (2002). Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 30:495-501.
22. Shaughnessy P, CL Bachier, L Long, et al. G-CSF mobilizes more dendritic cells and dendritic cell subsets compared to GM-CSF with no polarization of dendritic cell subsets in normal donors. Stem Cells (in press).
23. Morse MA, JJ Vredenburgh, HK Lyerly, et al. (1999). A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy. J Hematother Stem Cell Res 8:577-584.
24. Lonial S, M Hicks, H Rosenthal, et al. (2004). A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biol Blood Marrow Transplant 10:848-857.
25. Ferrari S, B Rovati, C Porta, et al. (2003). Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor. Cancer Immunol Immunother 52:359-366.
26. Shier LR, KR Schultz, S Imren, et al. (2004). Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 10:624-634.
27. Tayebi H, F Kuttler, P Saas, et al. (2001). Effect of granulocyte colony-stimulating factor mobilization on pheno-typical and functional properties of immune cells. Exp Hematol 29:458-470.
28. Sanchez J, C Herrera, A Torres, J Roman-Gomez, and MA Alvarez. (2004) Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid lin neg CD11cpos dendritic precursor cells. Br J Haematol 124:636-644.
29. + peripheral blood stem cells (PBSC) and dendritic cells (DCs) by AMD3100 in hard to mobilize non-Hodgkin's lymphoma (NHL) patients (patients) mobilized with standard dose of G-CSF. Blood 104:781 A.
30. Gazitt Y, C Akay, and C Thomas. (2004). Mobilization of type 1 and type 2 dendritic cells in non-Hodgkin's lymphoma patients mobilized with G-CSG, GM-CSF and GM-CSF followed by G-CSF. Cancer Res 95: abstract #4670.